TGFB1 and chronic myelogenous leukemia, BCR-ABL1 positive: In addition, TGF-β1 has also been found to be enriched in CML-exosomes and treatment with TGF-β1 receptor inhibitor (SB) significantly reduces exosome-stimulated cell proliferation and colony formation of CML cells.